Type-1 Regulatory T-Cell Frequencies Fluctuate in the First 6 Months of Peanut Oral Immunotherapy

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2017.12.735
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Dendritic Cell Frequencies Are Early Markers of Desensitization in Peanut Oral Immunotherapy

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Peanut Allergy and Oral Immunotherapy

Hong Kong Medical Journal
Medicine
2019English

T-Regulatory Cell Modulation: The Future of Cancer Immunotherapy?

British Journal of Cancer
Cancer ResearchOncology
2009English

AR101 Oral Immunotherapy for Peanut Allergy

Pediatrics
Child HealthPediatricsPerinatology
2019English

Changing the Outcomes of Peanut Oral Immunotherapy (POIT)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Sequential Hypoallergenic Boiled Peanut and Roasted Peanut Oral Immunotherapy

Clinical and Experimental Allergy
AllergyImmunology
2017English

The Safety of Peanut Oral Immunotherapy in Peanut-Allergic Subjects in a Single-Center Trial

International Archives of Allergy and Immunology
MedicineAllergyImmunology
2012English

Differences in Phenotype, Homing Properties and Suppressive Activities of Regulatory T Cells Induced by Epicutaneous, Oral or Sublingual Immunotherapy in Mice Sensitized to Peanut

Cellular and Molecular Immunology
Infectious DiseasesMedicineAllergyImmunology
2016English

T Cell Epitope Immunotherapy Induces a CD4+ T Cell Population With Regulatory Activity

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy